Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/5914
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrockway, Meredith (Merilee)-
dc.contributor.authorDaniel, Allison I.-
dc.contributor.authorReyes, Sarah M.-
dc.contributor.authordkk.-
dc.date.accessioned2024-09-20T07:53:22Z-
dc.date.available2024-09-20T07:53:22Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/5914-
dc.description.abstractHuman milk (HM) contains macronutrients, micronutrients, and a multitude of other bioactive factors, which can have a long-term impact on infant growth and development. We systematically searched MEDLINE, EMBASE, Cochrane Library, Scopus, and Web of Science to synthesize evidence published between 1980 and 2022 on HM components and anthropometry through 2 y of age among term-born infants. From 9992 abstracts screened, 141 articles were included and categorized based on their reporting of HM micronutrients, macronutrients, or bioactive components. Bioactives including hormones, HM oligosaccharides (HMOs), and immunomodulatory components are reported here, based on 75 articles from 69 unique studies reporting observations from 9980 dyads. Research designs, milk collection strategies, sampling times, geographic and socioeconomic settings, reporting practices, and outcomes varied considerably. Meta-analyses were not possible because data collection times and reporting were inconsistent among the studies included. Few measured infant HM intake, adjusted for confounders, precisely captured breastfeeding exclusivity, or adequately described HM collection protocols. Only 5 studies (6%) had high overall quality scores. Hormones were the most extensively examined bioactive with 46 articles (n ¼ 6773 dyads), compared with 13 (n ¼ 2640 dyads) for HMOs and 12 (n ¼ 1422 dyads) for immunomodulatory components. Two studies conducted untargeted metabolomics. Leptin and adiponectin demonstrated inverse associations with infant growth, although several studies found no associations. No consistent associations were found between individual HMOs and infant growth outcomes. Among immunomodulatory components in HM, IL-6 demonstrated inverse relationships with infant growth. Current research on HM bioactives is largely inconclusive and is insufficient to address the complex composition of HM. Future research should ideally capture HM intake, use biologically relevant anthropometrics, and integrate components across categories, embracing a systems biology approach to better understand how HM components work independently and synergistically to influence infant growth.en_US
dc.language.isoen_USen_US
dc.publisherAdvances in Nutritionen_US
dc.relation.ispartofseriesReview;100127-
dc.subjecthuman milken_US
dc.subjectbreastmilken_US
dc.subjectbreastfeedingen_US
dc.subjectinfanten_US
dc.subjectanthropometryen_US
dc.subjectbioactivesen_US
dc.subjecthormonesen_US
dc.subjecthuman milk oligosaccharidesen_US
dc.subjectimmunomodulatoryen_US
dc.subjectmetabolomicsen_US
dc.subjectbody compositionen_US
dc.subjectgrowthen_US
dc.subjectlactationen_US
dc.titleHuman Milk Bioactive Components and Child Growth and Body Composition in the First 2 Years: A Systematic Reviewen_US
dc.typeArticleen_US
Appears in Collections:VOL 15 NO 1 (2024)

Files in This Item:
File Description SizeFormat 
13. Human-Milk-Bioactive-Components-and-Child-Growth-a-Review.pdf1001272.71 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.